ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Phoenix, AZ

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Phoenix, AZ, USA:

Locations recently updated

Alpha Radiation Emitters Device for the Treatment of Pancreatic Cancer Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer

This is a multi-center clinical study enrolling up to 30 participants (15 patients in each cohort). The primary objective of the study is to evaluate...

Enrolling
Metastatic Pancreatic Cancer
Pancreatic Adenocarcinoma
Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
Alpha Tau Medical

Scottsdale, Arizona, United States and 15 other locations

is to assess the efficacy and safety of Acoustic Cluster Therapy (ACT) when given in addition to chemotherapy for treatment of Locally Advanced Pancreatic...

Enrolling
Locally Advanced Pancreatic Adenocarcinoma
Drug: Modified FOLFIRINOX
Combination Product: Acoustic Cluster Therapy

Phase 2

EXACT Therapeutics

Scottsdale, Arizona, United States

drugs, Vemurafenib and Sorafenib, in individuals with KRAS mutated pancreatic cancer who have progressed on standard chemotherapy....

Active, not recruiting
Pancreas Cancer
Drug: Sorafenib
Drug: Vemurafenib

Phase 2

HonorHealth Research Institute

Scottsdale, Arizona, United States

+ gemcitabine + cisplatin, and oral medications of chloroquine and celecoxib help patients with previously untreated metastatic pancreatic ...

Enrolling
Pancreatic Cancer Metastatic
Pancreatic Adenocarcinoma Metastatic
Drug: Balstilimab
Drug: Celecoxib

Phase 1

HonorHealth Research Institute

Scottsdale, Arizona, United States

This is a Phase 1b/2, open-label, multi-center, competitive enrollment and dose-escalation study of HCW9218 in patients with advanced/metastatic pancreatic...

Active, not recruiting
Advanced Pancreatic Carcinoma
Drug: HCW9218

Phase 1, Phase 2

ImmunityBio
ImmunityBio

Scottsdale, Arizona, United States and 4 other locations

compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Drug: Gemcitabine
Drug: Nab-paclitaxel

Phase 2

Agenus
Agenus

Scottsdale, Arizona, United States and 35 other locations

PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...

Enrolling
Solid Tumor
Breast Cancer
Drug: SON-DP

Phase 1

Qurgen

Gilbert, Arizona, United States and 4 other locations

to participants. Part C will use the information from Parts A and B to see if PF-08046049/SGN-BB228 is safe and if it works to treat solid tumor...

Active, not recruiting
Non-small Cell Lung Cancer
Colorectal Neoplasms
Drug: PF-08046049

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Phoenix, Arizona, United States and 32 other locations

The goal of this study is to test A2B530,an autologous logic-gated Tmod™ CAR T-cell product in subjects with solid tumors including colorect ...

Active, not recruiting
Solid Tumor
Non Small Cell Lung Cancer Recurrent
Biological: A2B530
Diagnostic Test: xT-Onco with HLA-LOH Assay

Phase 1, Phase 2

A2 Biotherapeutics

Gilbert, Arizona, United States of America and 7 other locations

The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard(s) of care (SOC) treatment.

Enrolling
PDAC - Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer
Drug: 5-fluorouracil
Drug: leucovorin

Phase 3

Revolution Medicines
Revolution Medicines

Phoenix, Arizona, United States and 46 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems